LBBW Index/Partizip. Zert BAYN 28.../ DE000LB4E975 /
09/01/2025 09:20:54 | Chg.+0.05 | Bid16:20:41 | Ask16:20:41 | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
53.36EUR | +0.09% | 53.82 Bid Size: 250,000 |
53.92 Ask Size: 250,000 |
BAYER AG NA O.N. | 41.19 - | 28/08/2026 | Call |
GlobeNewswire
02/08/2024
Arch Biopartners’ Cilastatin Drug Candidate to Participate in the PONTIAC Phase II Trial Targeting A...
GlobeNewswire
11/07/2024
AskBio receives FDA Fast Track and MHRA Innovation Passport designations for AB-1005 investigational...
GlobeNewswire
30/05/2024
Bayer and Burning Rock collaborate to increase patient access to precision cancer medicines
GlobeNewswire
30/05/2024
BlueRock Therapeutics receives FDA Regenerative Medicine Advanced Therapy designation for Parkinson’...
GlobeNewswire
28/05/2024
Pairwise and Bayer Expand CRISPR Leafy Greens Market through Licensing Agreement
GlobeNewswire
02/05/2024
AskBio Announces Nine Presentations at American Society of Gene and Cell Therapy 27th Annual Meeting...
GlobeNewswire
18/04/2024
AskBio receives FDA Fast Track Designation for AB-1002 investigational gene therapy program in conge...
GlobeNewswire
16/04/2024
AskBio presents 18-month Phase Ib trial results of AB-1005 gene therapy for patients with Parkinson’...
GlobeNewswire
11/04/2024
Daré Bioscience Announces Publication in Contraception of Positive Efficacy and Safety Findings from...
GlobeNewswire
25/03/2024
BlueRock Therapeutics and Foundation Fighting Blindness announce collaboration to expand the Uni-Rar...
GlobeNewswire
06/03/2024
BlueRock Therapeutics phase I clinical trial for Parkinson’s disease continues to show positive tren...
GlobeNewswire
04/03/2024
BridgeBio Pharma and Bayer Announce European Licensing Agreement for Acoramidis in ATTR-CM
GlobeNewswire
15/02/2024
2Blades Delivers on Project with Bayer Crop Science to Combat Asian Soybean Rust
GlobeNewswire
13/02/2024
Corporate Alignment with Climate Goals Under Scrutiny: LyondellBasell & Bayer demonstrate good pract...
GlobeNewswire
13/02/2024
First patient randomized in AskBio Phase II gene therapy trial for congestive heart failure